5 Best Genomics Stocks To Buy Now

Page 1 of 5

In this piece, we will take a look at the five best genomics stocks to buy now. If you want to learn more about the revolutionary genomics industry, then check out 12 Best Genomics Stocks To Buy Now.

5. Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Number of Hedge Fund Investors In Q3 2023: 27

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a gene editing company developing treatments for cancer and immune system diseases. Its shares are rated Strong Buy on average and analysts have set an average share price target of $76.

By the end of Q3 2023, 27 out of the 910 hedge funds part of Insider Monkey’s research had invested in Intellia Therapeutics, Inc. (NASDAQ:NTLA). Catherine D. Wood’s ARK Investment Management was the largest shareholder through its $314 million stake.

Follow Intellia Therapeutics Inc. (NASDAQ:NTLA)

Page 1 of 5